Gene chimeric human adenovirus and its construction method and application

Through the construction of genetic chimeric human adenovirus, the problems of safety risks and limited use of existing adenovirus vaccines have been solved, and the attenuation and efficient expression of adenoviruses are achieved, providing a safe and effective vaccine and genetically modified therapy vector. .

CN117821405BActive Publication Date: 2024-11-26GUANGZHOU MEDICAL UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202311576004.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-24
Publication Date
2024-11-26
Estimated Expiration
2043-11-24

AI Technical Summary

Technical Problem

Existing adenovirus vaccines have safety risks and limited use, especially the risk of live virus contamination in the environment is high, and there is a lack of safe and effective research on attenuated adenovirus vaccines.

Method used

Through the construction of a gene chimeric human adenovirus, the specific method includes replacing the E4orf6 region of the target human adenovirus with the E4orf6 region of HAd5, and inserting an exogenous gene expression box in the E3 region to prepare a gene chimeric human adenovirus. Such as Ad7-dE3E-A5E4, the virus is attenuated and efficiently expressed.

Benefits of technology

Achieve significant attenuation of the chimeric human adenovirus, improves safety and scope of use, can be used as a vaccine vector and a transgenic therapy vector, with more efficient exogenous gene expression and lower cost, suitable for commonly used HEK Prepared in -293 cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117821405B_ABST
    Figure CN117821405B_ABST
Patent Text Reader

Abstract

The present application relates to the field of biotechnology, and in particular to a gene-chimeric human adenovirus and its construction method and application. In the gene-chimeric human adenovirus, the E4orf6 region in its genome is replaced by the E4orf6 region of HAd5, and the gene-chimeric human adenovirus and the human Ad5 adenovirus belong to different subgroups. The gene-chimeric human adenovirus prepared in the embodiment of the present application: has achieved significant attenuation relative to the wild-type adenovirus, and the use thereof to prepare drugs has higher safety and a wider range of uses; it can be used as a vaccine vector and a transgenic therapy vector, the genome can replicate, and it has the characteristics of more efficient expression of exogenous genes and lower cost; it can be efficiently prepared in commonly used HEK‑293 cells, etc., without the need to prepare complementary cell lines separately.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Cited By

  • Construction method and application of adenovirus infected animal model

    CN121753758A